Cleansing prospectus
Cleansing prospectus
ASX Announcements
Change of Director's Interest Notice – Dr Andreas Lindner
Change of Director’s Interest Notice – Dr Andreas Lindner
Proposed issue of Securities – IVQ
Proposed issue of Securities – IVQ
Significant investment and joint venture with a fund
Significant investment and joint venture with a fund
Results of Annual General Meeting – 2019
Results of Annual General Meeting
Quarterly Appendix 4C
Quarterly Appendix 4C
Notice of Annual General Meeting – 2019
Notice of Annual General Meeting
Appendix 4E – 2019
Appendix 4E
Invitrocue Establishes Hong Kong Laboratory
Invitrocue Establishes Hong Kong Laboratory Innovative life sciences company Invitrocue Limited (ASX: IVQ) (‘Invitrocue’ or ‘the Company’) is pleased to announce the establishment of laboratory facility in Hong Kong. The Hong Kong facility, which will be used for research and development and for commercial purposes, provides Invitrocue with better access to the network of supportive …
Invitrocue Clinical Studies underway in Germany
Invitrocue Clinical Studies underway in Germany Innovative life sciences company Invitrocue Limited (ASX: IVQ) (‘Invitrocue’ or ‘the Company’) is pleased to announce that a clinical validation study is underway for its Onco-PDO test with Klinikum Rechts der Isar der Technischen Universitat Munchen, Comprehensive Cancer Center Munich, Germany.